Written by leading prescribers, these resources are designed to help you practise safely, confidently, and in line with regulatory expectations. Whether you’re prescribing now or preparing to, every document gives you clear, trusted information grounded in clinical experience and evidence. This is the toolkit regulators want to see you using.
Managing CBPMs in UK Hospitals & Care Settings
July 2025
About the guide
Managing Cannabis-Based Medicinal Products in UK Hospitals and Care Settings is written for doctors, nurses, pharmacists, anaesthetists, surgeons and care providers across secondary and palliative care.
It’s designed to support anyone searching for CBPM hospital policy, managing medical cannabis prescriptions during hospital or hospice admissions, or simply how to stay compliant when supporting patients with legal medical cannabis prescriptions.
The MCCS hope this guide will provide much-needed clarity for all clinicians and patients wishing to understand the law and guidance around using CBPMs in hospital, hospice, and all in-patient care settings.
Good Practice Guide for Prescribers of CBPMs – Updated
July 2025
About the guide
The aim of this guide to good practice is to help prescribers and patients access this valuable medicine. These guidelines are specifically designed for clinics that primarily prescribe cannabis, though the foundational principles should be relevant across clinics with a broader medical focus. Variations in application may occur, but the standards of practice are intended to be universally applicable.
The MCCS hopes that this document on good practices will be embraced by all prescribers and clinics, ensuring that patients are provided with this medicine in a manner that is both safe and supportive.
Such an approach benefits not only the patients but also enhances the overall integrity of the industry.
MCCS Recommendations & Guidance
February 2021
About the guide
First published in 2019, the Medical Cannabis Clinicians Society worked with the All-Party Parliamentary Group for Medical Cannabis under Prescription to produce its guidance for medical cannabis.
Updated for 2021, version 3 of Recommendations and Guidance on Medical Cannabis under Prescription (3rd edition) by The Medical Cannabis Clinicians Society sets out the facts about medical cannabis treatments – history, evidence and prescribing information.
Commentary & critique of BPNA Guidance
December 2021
About the guide
In 2021, the BPNA produced guidance on the prescription of cannabis medicines for children with epilepsy.
Unfortunately, the Medical Cannabis Clinicians Society and Drug Science fundamentally disagree with this guidance. So, our expert clinicians have produced a critique to provide commentary, evidence and further crucial information.
Publications available to Society members
Guidance for Pharmacists dispensing CBPMs
April 2025
About the guide
Developed specifically for pharmacy professionals, this guidance for members provides a comprehensive overview of dispensing cannabis-based medicinal products in the UK.
The Pharmacy Guidance gives pharmacists a clear overview of everything they need to know when working with cannabis-based medicines. It explains how these medicines became legal, what they are, how they work, and the different types available. It also covers who can prescribe them, how they should be dispensed, possible side effects and drug interactions, and what checks pharmacists need to carry out. There’s also practical information on prescription forms, record-keeping, and controlled drug rules, as well as a glossary to explain key terms.
Members can access this guidance as part of our Member’s Hub. To access, please join the Society.
FAQs for Prescribers of CBPMs
June 2024
About the guide
This Member’s Only guide is your go-to resource for understanding the ins and outs of prescribing medical cannabis in the UK. It covers everything from detailed information on licensed and unlicensed cannabis-based medicines to regulatory guidelines and practical templates for clinical use.
Designed to support your practice, this publication answers common questions and offers peer-reviewed content that’s essential for informed decision-making. Remember, this resource is shaped by your experience and insights as well—your contributions help enhance its value and relevance.
How to prescribe medical cannabis in the UK
June 2024
About the guide
Many clinicians contact the Medical Cannabis Clinicians Society looking for clarity about what is and is not permitted when it comes to prescribing this treatment option for patients.
The information which follows guides you through the steps required to satisfy these requirements, with further information about the practical steps you should take to ensure you are confident, compliant and well informed.
How to talk to patients about medical cannabis
May 2023
About the guide
According to research carried out by the Centre for Medicinal Cannabis in 2019, 1.4m people in the UK have used cannabis for medical reasons and over 11% of UK adults (6 million people) have tried a CBD product.
So, how should you be talking to your patients about medical cannabis?
In this guide for UK clinicians, our expert committee and patients advise.
CBD: Recommendations for Good Practice
May 2022
About the guide
The Medical Cannabis Clinicians Society has considered the criteria that a medical practitioner would want to see in a good quality CBD product.
The issue for CBD products is that there have been instances where products breach the applicable regulatory standards, either in label claims, quality, or the Misuse of Drugs Regulations. As such, we set out relevant criteria we see as necessary for products to make the grade.
This guide should be used in conjunction with The Clinicians Guide to CBD.
CBMP Prescribing Guidelines
Update coming late 2025
About the guide
When it comes to prescribing medical cannabis for the first time, many clinicians have questions about the best approach. The basic principle is to start low and go slow. This Member’s Only guide, along with expert training, will support you to prescribe safely.
A Clinician’s Guide to CBD
Updated 2021
About the guide
This guide provides an overview of CBD for clinicians, including its modes of action and therapeutic effects, pharmacodynamics and dosing.
We also summarise the current legal status of CBD in the UK.
We hope the information contained in this publication will help doctors understand CBD and help guide their patients to the safest and most effective and evidence-based products available.
These publications aren’t available anywhere else. They’re created by clinicians, for clinicians — and they’re only accessible through UKMCCS membership. Whether you’re looking for guidance, reassurance, clarity or credibility, our resources are here to support you every step of the way.
Ready to access it all?
Join the Society today and start using the UK’s most trusted library of medical cannabis clinical guidance.